The p62-Keap1-Nrf2 pathway also plays a central role in the prevention of HCC by acting against sorafenib-induced ferroptosis by upregulating genes (notably –HO-1 and FTH1) involved in iron and ROS metabolism [36]. This evidence concerns the gene NFE2L2 and hepatocellular carcinoma.